Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Blood Transfusion01:15

Blood Transfusion

2.4K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
2.4K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

14.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
14.8K
Structure and Function of Platelets01:18

Structure and Function of Platelets

3.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.6K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

9.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.3K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Targeting nuclear export and Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signalling in myelofibrosis: A novel combinatorial strategy that impacts intrinsic and microenvironment-related pathways.

British journal of haematology·2026
Same author

Menin-dependent megakaryocyte proliferation and fibrosis in myeloproliferative neoplasms.

Cancer cell·2026
Same author

Linezolid Acts as a Selective Inhibitor of the JAK2 <sup>V617F</sup> Mutation.

bioRxiv : the preprint server for biology·2026
Same author

Long term outcomes of idasanutlin therapy in hydroxyurea-refractory polycythemia vera patients.

Leukemia & lymphoma·2026
Same author

Inhibition of the EBF1-ITGB8 Axis in Bone Marrow Niche Ameliorates Hallmarks of Myelofibrosis.

bioRxiv : the preprint server for biology·2026
Same author

Wnt-dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis.

HemaSphere·2026

関連する実験動画

Updated: Feb 7, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.6K

輸血 の ため に 血小板 を 流す

Camelia Iancu-Rubin1, Ronald Hoffman1, Anna Rita Migliaccio2

  • 1Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.

Cell
|July 28, 2018
PubMed
まとめ

研究者達は 動乱が体内で血小板の生成を 制御することを発見しました この発見は,ヒト誘発性多能幹細胞 (iPSC) の機能性血小板の大規模臨床生産のためのバイオリアクターで使用できます.

科学分野:

  • バイオテクノロジー
  • 血液学
  • 再生医療

背景:

  • 血小板 輸血 は,様々な 病気 の 治療 に 極めて 重要 な もの です.
  • 現在 血小板の供給は ヒトのドナーに大きく依存しており 需要を満たすには 課題があります
  • 十分な信頼性の高い供給を確保するために,大規模なex vivo血小板生産が必要である.

研究 の 目的:

  • 血小板生成の物理的レギュレータを in vivo で調査する.
  • 臨床的なスケールでの血小板生成のためのこれらのレギュレータの活用の可能性を調査する.
  • 人間の誘発性多能幹細胞 (iPSC) から機能性血小板を生成する方法を開発する.

主な方法:

  • メガカリオポエーゼスと血小板の放出における物理的力,特に乱流の役割を調査した.
  • 生理学的乱流を模倣する バイオリアクターシステムを開発した
  • 血小板生成の出発材料としてヒト誘発性多能幹細胞 (iPSC) を利用した.

主要な成果:

  • 血小板形成の重要な物理的調節因子として,in vivoで動乱を特定した.
  • バイオリアクターの制御された乱れが iPSC から効率的な血小板生成を促進することを実証した.

さらに関連する動画

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.4K
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

10.0K

関連する実験動画

Last Updated: Feb 7, 2026

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.6K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.4K
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

10.0K
  • 臨床用途に適したスケールで機能的な血小板を生成する.
  • 結論:

    • トルブランスは 血小板の自然生成の 重要な要因です
    • バイオリアクタベースの生産は,流血可能な血小板の需要を満たすための有望な戦略を提供します.
    • このアプローチは,ドナーのスクリーニングへの依存を軽減し,患者にとって血小板の可用性を高めることができます.